EP3268031 - Bibliographic data
COMBINATION OF TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A PD-1 AND/OR PD-L1 INHIBITOR, FOR USE AS A MEDICAMENT
Last update | 11/07/2025 |
---|---|
Legal status | Brevet déchu |
Origin | Euro-PCT |
(73) Holder |
Active Biotech AB Scheelevägen 22
223 63 Lund
Suède
|
---|---|
(72) Inventors |
José Amauri SOARES 49 Rue de Chatenay
Bat Esterel 2
F-92160 Antony
France
Eric CHETAILLE 15 Rue de Neuilly
F-92110 Clichy
France
Jessica NAKHLE IPSEN INNOVATION
Z.I. de Courtaboeuf
5 avenue du Canada
91940 Les Ulis
France
Fabien SCHMIDLIN 4 Rue de la Mare
La Padole
F-91590 Mondeville
France
|
(74) Agent |
Mail recipient Brann AB P.O. Box 3690
Sveavägen 63
103 59 Stockholm
Suède
|
(21) Request number | EP16705122.6 |
---|---|
(22) Request date | 16/02/2016 |
(11) Publication number | EP3268031 |
---|---|
Publication date | 04/11/2020 |
(54) Title of the invention | COMBINATION OF TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A PD-1 AND/OR PD-L1 INHIBITOR, FOR USE AS A MEDICAMENT |
---|---|
(51) International classification | A61K 31/4704, A61K 39/395, A61K 39/00, A61K 45/06, A61P 35/00, C07K 16/28 |
International classification (before reform) | None |
Claimed priority |
(31) Number: 15290069 |
---|---|
Initial application | None |
Divisional application | None |
Expected annuity |
Annuity: 6 -
Amount: 120 € -
Due date 01/03/2021
Surtax: 6 - Amount: 24 € - Due date 02/09/2021 |
---|---|
Last annuity | None |
Publication | None |
---|---|
History | Publication de la délivrance du brevet européen - Legal date 04/11/2020 Entrée en période de grâce du brevet d'invention - Legal date 02/03/2021 Déchéance du brevet d'invention après période de grâce - Legal date 01/03/2021 |